Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05599061 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Treatment of Functionally Non-significant Vulnerable Plaques in Patients With Multivessel ST-elevation Myocardial Infarction The VULNERABLE Trial

Study acronym: VULNERABLE
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status changed: Recruiting → Active, Not Recruiting Enrollment target: estimated 600 to confirmed 609 · Site details revised at 49 of 49 sitesv48 Show 2 more changesShow less
    • Enrollment target: estimated 600 to confirmed 609
    • Site details revised at 49 of 49 sites
  2. Study sites: 48 to 49v47
  3. Study sites: 46 to 48v46
  4. Study sites: 45 to 46v45
  5. Study sites: 44 to 45v44
Show 42 earlier versionsHide 42 earlier versions
  1. Study sites: 43 to 44v43
  2. Study sites: 42 to 43v42
  3. Study sites: 41 to 42v41
  4. Study sites: 40 to 41v40
  5. Study sites: 39 to 40v39
  6. Study sites: 38 to 39v38
  7. Study sites: 37 to 38v37
  8. Study sites: 36 to 37v36
  9. Study sites: 35 to 36v35
  10. Study sites: 34 to 35v34
  11. Study sites: 33 to 34v33
  12. Study sites: 32 to 33v32
  13. Study sites: 31 to 32v31
  14. Study sites: 30 to 31v30
  15. Study sites: 29 to 30v29
  16. Study sites: 28 to 29v28
  17. Study sites: 27 to 28v27
  18. Study sites revised (27)v26 See this version in full on ClinicalTrials.gov ↗
  19. Study sites: 26 to 27v25
  20. Study sites: 25 to 26v24
  21. Study sites: 23 to 25v23
  22. Study sites: 21 to 23v22
  23. Study sites: 20 to 21v21
  24. Study sites: 19 to 20v20
  25. Study sites: 18 to 19v19
  26. Study sites: 17 to 18v18
  27. Study sites: 15 to 17v17
  28. Study sites: 14 to 15v16
  29. Study sites: 12 to 14v15
  30. Study sites: 11 to 12v14
  31. Study sites: 10 to 11v13
  32. Study sites: 9 to 10v12
  33. Study sites: 8 to 9v11
  34. Study sites: 7 to 8v10
  35. Study sites: 6 to 7v9
  36. Study sites: 5 to 6v8
  37. Study sites: 1 to 5v7
  38. Re-verified, no change to tracked fieldsv6
  39. Trial status: Not Yet Recruiting to Recruiting Study sites: 0 to 1 · Start date changed from estimate of Feb 1, 2023 to Jan 30, 2023v5 Show 2 more changesShow less
    • Study sites: 0 to 1
    • Start date changed from estimate of Feb 1, 2023 to Jan 30, 2023
  40. Start date: Dec 1, 2022 to Feb 1, 2023v4
  41. Eligibility criteria shortened, about 2 wordsv3 See this version in full on ClinicalTrials.gov ↗
  42. Study title shortened, about 1 wordv2 See this version in full on ClinicalTrials.gov ↗
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The study aims to compare a preventive percutaneous coronary intervention (PCI) plus optimal medical treatment (OMT) strategy vs. OMT for treatment of non-functionally significant non-culprit lesions presenting with optical coherence tomography (OCT) findings indicative of vulnerable plaque, in patients with ST-elevation myocardial infarction (STEMI) and multivessel disease.
Trial Details
NCT Number NCT05599061
Lead Sponsor Fundación EPIC
Collaborators: Abbott
Conditions Coronary Artery Disease, Coronary Disease, Ischemic Heart Disease
Enrollment 609 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov